NYLI Healthy Hearts ETF HART
30.67 USD +0.10 (+0.32%)
Aug 19, 2025, 12:03 PM EDT
30.67 Day range 30.67
28.56 52-week range 34.43
- YTD
- +0.07%
- 1 year
- -6.00%
News
benzinga.com World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate.
benzinga.com Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
etftrends.com Rising Pharma Prices Could Give a Beat to HART ETF Data indicate that inflation is easing. Add to that, the Inflation Reduction Act, which passed last year, allows Medicare to negotiate prices on some popular drugs with pharmaceutical companies.
seekingalpha.com Can Health Care Stocks Outperform Again In 2023? How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
etftrends.com Healthcare Could Be a Healthy Sector Bet in 2023 The healthcare sector, the second-largest sector allocation in the S&P 500, performed significantly less poorly than the broader market in 2022 and that relative sturdiness has some market observers…
etftrends.com Reliability Carried the Day for Healthcare Sector in 2022 With just two trading days left in 2022, it's safe to say the healthcare sector was significantly less bad than the broader market. As of December 27, the S&P 500 Health Care Index was down just 2.2%…
etftrends.com HART Heavy on Healthcare Bounce Back Plays With compelling long-term opportunities available across multiple industry groups, healthcare has the makings of a 2023 redemption, potentially boding well for exchange traded funds such as the IQ…
etftrends.com Healthcare Could Be Healthy 2023 Sector Bet The defensive healthcare sector is living up to its billing this year, as the S&P 500 Health Care Index is lower by just 0.72% compared to 15.37% for the S&P 500.
etftrends.com HART Helpful for Avoiding Healthcare ESG Issues On the surface, healthcare appears to be a sector with obvious environmental, social, and governance (ESG) credentials, meaning it's not surprising the group is prominent in an array of ESG exchange…
etftrends.com FDA Rebound Could Help HART Beat Higher Experienced healthcare investors know that the Food & Drug Administration (FDA) often looms large. After all, that is the regulatory body that has the final say in whether or not biotechnology and…
etftrends.com HART Helpful Idea for Healthcare Defense The healthcare sector is in the red this year, but its defensive traits are helping the group sharply outperform the broader market. That could be an encouraging sign for healthcare exchange traded…
etftrends.com HART Beat to Practical Healthcare ETF Investors looking to capitalize on the healthcare sector's defensive and quality traits while contributing to the greater good have an appealing idea thanks to the IQ Healthy Hearts ETF (HART). HART…
etftrends.com HART ETF Living Up to Dual Impact Mission Impact investing is garnering more attention, but it's often framed in terms of a style — not something that's applicable for funds to perform. However, it is possible for money managers to do right…
etftrends.com HART Healthy With Attractively Valued Stocks Broadly speaking, the healthcare sector, perhaps owing to its defensive properties, is seen as fairly valued. However, there are plenty of individual stocks within this group that are considered…
etftrends.com HART: A Beat on Unique Healthcare Investing Investors can do good for the world at large while still profiting, and that effort isn't confined to environmental, social, and governance (ESG) strategies. Take the case of the IQ Healthy Hearts…
etftrends.com Why Investment into Women's Heart Health is Desperately Needed The American Heart Association's most recent Presidential Advisory addressed the large gap in research between men's heart health and women's. In a world where men's heart health has become the gold…
etftrends.com This Pharmaceutical Company Is Growing — Here's How to Invest Last week, Danish pharmaceutical company Novo Nordisk announced its first quarter earnings beating estimates, raising its growth outlook for the rest of 2022 and expanding its buyback program,…
etftrends.com Better Healthcare Really Does Lead to Longer Lives Researchers from the Framington Heart Study, a multi-generational study that began in 1948, have found that men and women are living longer and incidents of heart disease are occurring later in life…
etftrends.com How to Invest in Diversity, Heart Health, and Good Causes Regulation concerning ESG metrics reported by countries and utilized by funds is in the works in the U.S. For now, however, regulation remains nonexistent as the SEC ponders how to apply a regulatory…
etftrends.com Nearly Half of Americans Have Had Heart Issues Since Pandemic Approximately 40% of Americans have experienced a heart-related issue since the onset of the COVID-19 pandemic, according to a study from the Cleveland Clinic. Lifestyle changes, stress, increased…
etftrends.com Healthcare Industry Set for Spectacular Innovation in Next Decade The new CEO of Johnson & Johnson, Joaquin Duato, believes that healthcare will experience greater innovations in the next 10 years than it has over the entirety of the previous century, reports CNBC.…
etftrends.com Investing in Heart Health as Pandemic Eases The newest cycle of COVID-19 infections may finally signal a downshift to an endemic according to a leading epidemiologist, reports CNBC. Omicron BA.2 spreads 80% faster than Omicron and is on its…